Dominant mutations in the proopiomelanocortin gene (POMC) are reported to cause severe, early-onset obesity in affected patients, often with other neuroendocrine features consistent with the diverse physiological roles of the multiple POMC-derived peptides [43,44,45,46]. This evidence concerns the gene POMC and obesity due to melanocortin 4 receptor deficiency.